Evidence map›Paper›PMID 42416785›Full record

ArticleJournal of human immunity2026

Chronic granulomatous disease: A multicenter study from the MENA region.

Salem Al-Tamemi, Najla Mekki, Fatima Ailal, Raed Alzyoud, Waleed Al-Herz, Maryam Al-Nesf, Nesrine Radwan, Iman Nasr, Musab Al Jabri, Thouraya Kammoun and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of human immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Salem Al-TamemiDepartment of Child Health, Sultan Qaboos University Hospital, University Medical Center, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.ORCID https://orcid.org/0000-0002-7232-2629
Najla MekkiLaboratory of Transmission, Control and Immunobiology of Infections (LR16IPT02), Institut Pasteur de Tunis, Faculty of Medicine of Tunis, Université Tunis El Manar, Tunis, Tunisia.ORCID https://orcid.org/0000-0002-5842-9147
Fatima AilalDepartment of Pediatrics, Laboratory of Clinical Immunology, Inflammation and Allergy, Faculty of Medicine and Pharmacy of Casablanca, University of Hassan II, Casablanca, Morocco.ORCID https://orcid.org/0000-0001-5824-3193
Raed AlzyoudDepartment of Pediatric Allergy, Immunology, and Rheumatology, Queen Rania Children's Hospital, Amman, Jordan.ORCID https://orcid.org/0000-0002-4972-5809
Waleed Al-HerzDepartment of Pediatrics, College of Medicine, Kuwait University, Kuwait City, Kuwait.ORCID https://orcid.org/0000-0003-4244-4489
Maryam Al-Nesf *Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0001-9354-0214
Nesrine RadwanPediatric Allergy, Immunology & Rheumatology Unit, Ain Shams University, Cairo, Egypt.ORCID https://orcid.org/0000-0002-4334-4589
Iman NasrDepartment of Clinical Immunology and Allergy, Royal Hospital, Muscat, Oman.ORCID https://orcid.org/0000-0003-0346-9675
Musab Al JabriDepartment of Child Health, Sultan Qaboos University Hospital, University Medical Center, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.ORCID https://orcid.org/0009-0009-7582-522X
Thouraya KammounDepartment of Pediatrics, Hedi Chaker University Hospital, Sfax, Tunisia.ORCID https://orcid.org/0000-0002-1731-6162
Assma DablyLaboratory of Clinical Immunology, Inflammation and Allergy Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.ORCID https://orcid.org/0009-0007-1216-9806
Motasem AlsuweitiDepartment of Pediatric Allergy, Immunology, and Rheumatology, Queen Rania Children's Hospital, Amman, Jordan.ORCID https://orcid.org/0000-0001-9494-6312
Mehdi Adeli *Allergy and Immunology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.ORCID https://orcid.org/0000-0002-3051-3080
Eiman AbdallaDepartment of Child Health, Sultan Qaboos University Hospital, University Medical Center, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.ORCID https://orcid.org/0009-0001-6353-8786
Monia Ben KhaledFaculty of Medicine, University of Tunis El Manar, Tunis, Tunisia.ORCID https://orcid.org/0000-0003-3629-7515
Mohammad AlnoubaniDepartment of Pediatric Allergy, Immunology, and Rheumatology, Queen Rania Children's Hospital, Amman, Jordan.ORCID https://orcid.org/0009-0002-1334-6644
Hamza AlnsourDepartment of Pediatric Allergy, Immunology, and Rheumatology, Queen Rania Children's Hospital, Amman, Jordan.ORCID https://orcid.org/0009-0004-2995-6812
Imen Ben-MustaphaLaboratory of Transmission, Control and Immunobiology of Infections (LR16IPT02), Institut Pasteur de Tunis, Faculty of Medicine of Tunis, Université Tunis El Manar, Tunis, Tunisia.ORCID https://orcid.org/0000-0002-3526-2890
Monia OuederniFaculty of Medicine, University of Tunis El Manar, Tunis, Tunisia.ORCID https://orcid.org/0000-0003-3642-6743
Ahmed Aziz BousfihaDepartment of Pediatrics, Hassan II University, Laboratory of Clinical Immunology, Inflammation and Allergy, Casablanca, Morocco.ORCID https://orcid.org/0000-0002-5011-9873
Mohamed-Ridha BarboucheDepartment of Microbiology, Immunology and Infectious Diseases, College of Medicine and Health Sciences, Arabian Gulf University, Manama, Bahrain.ORCID https://orcid.org/0009-0009-4145-8644

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To study chronic granulomatous disease (CGD) in the Middle East and North Africa (MENA) region, we conducted a retrospective multicenter study to investigate the clinical features, infections, microorganisms, management, mortality, and survival of patients with CGDs. A total of 322 patients were included; the M:F ratio was 1.8, and the median ages at disease onset and diagnosis were 6.0 and 20.0 mo, respectively. The most common infections included pneumonia (58.0%), lymphadenitis (49.1%), skin abscesses/cellulitis (40.7%), and invasive pulmonary aspergillosis (17.7%). The most commonly isolated microorganisms were

Identifiers

PMID42416785
PMCPMC13340003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.